Raiffeisen Bank International AG Increases Holdings in Agilent Technologies, Inc. $A

Posted by Brenda Bartman on Sep 4th, 2026

Raiffeisen Bank International AG increased its position in Agilent Technologies, Inc. (NYSE:A – Free Report) by 7.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 73,572 shares of the medical research company’s stock after purchasing an additional 5,209 shares during the quarter. Raiffeisen Bank International AG’s holdings in Agilent Technologies were worth $9,773,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Agilent Technologies in the 4th quarter worth $549,158,000. Bank of New York Mellon Corp raised its holdings in shares of Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after acquiring an additional 2,440,360 shares in the last quarter. Legal & General Group Plc bought a new stake in shares of Agilent Technologies in the second quarter valued at about $260,101,000. AQR Capital Management LLC lifted its stake in Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after acquiring an additional 1,652,244 shares during the period. Finally, Bank of America Corp DE purchased a new stake in Agilent Technologies in the second quarter worth about $213,269,000.

Agilent Technologies Price Performance

A opened at $149.87 on Friday. The firm has a market capitalization of $42.25 billion, a PE ratio of 29.50, a price-to-earnings-growth ratio of 2.30 and a beta of 1.24. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The business’s 50-day moving average is $141.99 and its two-hundred day moving average is $127.71. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $163.75.

Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the firm posted $1.37 earnings per share. The company’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.2 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Sanford C. Bernstein raised their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a research report on Friday, August 28th. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. TD Cowen lifted their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Finally, Royal Bank Of Canada boosted their price objective on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average target price of $170.33.

Check Out Our Latest Report on Agilent Technologies

About Agilent Technologies

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.